Marsh & McLennan Companies (NYSE:MRSH) Price Target Cut to $206.00 by Analysts at JPMorgan Chase & Co.

Key Points

• JPMorgan cut its price target on MRSH from $226 to $206 but kept an "Overweight" rating; overall analyst sentiment is mixed with a consensus "Hold" and an average target of $208.38 (Wells Fargo notably lowered its target to $178).
• Marsh & McLennan beat quarterly estimates, reporting EPS of $2.12 vs. $1.97 expected and revenue of $6.60 billion, up 8.7% year‑over‑year.
• The stock traded at $173.12 (down about $2.69), with a market cap of ~$83.8B, a P/E of ~20.5 and a 52‑week range of $164.89–$239.34, reflecting a recent pullback versus analyst targets.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) had its price objective lowered by equities research analysts at JPMorgan Chase & Co. from $226.00 to $206.00 in a research note issued on Thursday,Benzinga reports. The brokerage currently has an "overweight" rating on the financial services provider's stock. JPMorgan Chase & Co.'s price objective would suggest a potential upside of 19.00% from the company's previous close.

Several other equities research analysts also recently issued reports on the company. Cantor Fitzgerald increased their price target on Marsh & McLennan Companies from $208.00 to $212.00 and gave the stock an "overweight" rating in a report on Monday, February 2nd. Citigroup increased their price target on Marsh & McLennan Companies from $201.00 to $205.00 and gave the stock a "neutral" rating in a report on Tuesday, February 3rd. Barclays lowered their price target on Marsh & McLennan Companies from $209.00 to $206.00 and set an "overweight" rating for the company in a report on Wednesday. Wells Fargo & Company lowered their price target on Marsh & McLennan Companies from $203.00 to $178.00 and set an "equal weight" rating for the company in a report on Thursday. Finally, Keefe, Bruyette & Woods decreased their price objective on Marsh & McLennan Companies from $206.00 to $200.00 and set a "market perform" rating for the company in a report on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, eleven have assigned a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $208.38.

Marsh & McLennan Companies Stock Performance

NYSE:MRSH traded down $2.69 during mid-day trading on Thursday, hitting $173.12. The company had a trading volume of 1,495,189 shares, compared to its average volume of 3,070,453. Marsh & McLennan Companies has a fifty-two week low of $164.89 and a fifty-two week high of $239.34. The company has a fifty day moving average price of $174.39. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 1.20. The stock has a market capitalization of $83.81 billion, a price-to-earnings ratio of 20.54, a P/E/G ratio of 2.38 and a beta of 0.75.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) last announced its quarterly earnings results on Thursday, January 29th. The financial services provider reported $2.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.97 by $0.15. Marsh & McLennan Companies had a return on equity of 31.60% and a net margin of 15.42%.The company had revenue of $6.60 billion during the quarter, compared to the consensus estimate of $6.52 billion. During the same period in the prior year, the company earned $1.87 earnings per share. The company's revenue for the quarter was up 8.7% compared to the same quarter last year. Equities analysts forecast that Marsh & McLennan Companies will post 9.61 earnings per share for the current year.

Insider Activity

In related news, CEO John Q. Doyle sold 16,655 shares of the stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $183.30, for a total transaction of $3,052,861.50. Following the completion of the transaction, the chief executive officer directly owned 116,811 shares in the company, valued at approximately $21,411,456.30. This trade represents a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.35% of the company's stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of MRSH. State Street Corp acquired a new position in Marsh & McLennan Companies during the fourth quarter valued at approximately $4,057,682,000. Capital International Investors acquired a new position in Marsh & McLennan Companies during the fourth quarter valued at approximately $3,482,557,000. Capital World Investors acquired a new position in Marsh & McLennan Companies during the fourth quarter valued at approximately $3,140,284,000. Wellington Management Group LLP acquired a new position in Marsh & McLennan Companies during the fourth quarter valued at approximately $2,967,927,000. Finally, Price T Rowe Associates Inc. MD acquired a new position in Marsh & McLennan Companies during the fourth quarter valued at approximately $1,710,101,000. 87.99% of the stock is owned by institutional investors and hedge funds.

Marsh & McLennan Companies News Roundup

Here are the key news stories impacting Marsh & McLennan Companies this week:

• Positive Sentiment: Barclays reaffirmed an Overweight/Buy view on MRSH, maintaining a constructive stance that supports upside potential. Article Title
• Positive Sentiment: Zacks highlights that MRSH appears positioned for an earnings beat — analysts point to the right mix of revenue and margin drivers ahead of results, which could buoy the stock if confirmed. Article Title
• Positive Sentiment: Marsh closed a small acquisition (Seitz Insurance Agency) to expand its Montana footprint and middle‑market distribution — a strategic tuck‑in that can drive cross‑sell and local revenue growth over time. Article Title
• Neutral Sentiment: Morgan Stanley reiterated a Hold on MRSH, which is unlikely to shift investor conviction materially but contributes to mixed analyst sentiment. Article Title
• Neutral Sentiment: Barclays trimmed its price target slightly (from $209 to $206) but kept an Overweight rating — a modest adjustment that still implies meaningful upside. Article Title
• Neutral Sentiment: Options activity suggests traders are positioning for a sizable move in MRSH, indicating higher near‑term volatility even if direction is uncertain. Article Title
• Neutral Sentiment: Consensus brokerage coverage remains clustered around Hold, keeping analyst guidance mixed overall. Article Title
• Negative Sentiment: Wells Fargo cut its price target sharply (from $203 to $178) and set an Equal Weight rating — the downgrade is the primary near‑term negative driver pressuring the stock today. Article Title

About Marsh & McLennan Companies

Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.